CNS PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$5.00
+4.82%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-4.6%
3 months
-13.6%
6 months
+116.4%
1 year
-33.4%
Year to date
-4.8%
52-week range
$2.13 – $7.84
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$7.3M
P/E
-0.4
P/B
0.4
P/S
—
Revenue
$0
Net income
-$16.7M
Diluted EPS
-23.59
Gross margin
—
Net margin
—
Return on equity
-204.30%
Total debt
$0
Cash
$19.99M
Free cash flow
-$13.42M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$2.59M | — | — | -$3.54M |
| Mar 31, 2026 | $0 | -$4.94M | — | — | -$4.65M |
| Dec 31, 2025 | $0 | -$5.96M | — | — | -$3.05M |
| Sep 30, 2025 | $0 | -$3.22M | — | — | -$2.17M |
| Jun 30, 2025 | $0 | -$2.37M | — | — | -$5.34M |
| Mar 31, 2025 | $0 | -$4.3M | — | — | -$3.24M |
| Dec 31, 2024 | $0 | -$3.18M | — | — | -$5.48M |
| Sep 30, 2024 | $0 | -$5.61M | — | — | -$6.8M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CNSP news
All market newsNo ticker-linked stories are in the current archive.